tiprankstipranks
Antengene Corporation Limited (HK:6996)
:6996

Compare Antengene Corporation Limited (6996) vs. Competitors

3 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Antengene Corporation Limited
HK$5.27
HK$3.56B
-9.15
116.85%
1 Buy
0 Hold
0 Sell
Moderate Buy
Ascletis Pharma, Inc.
HK$17.95
HK$19.05B
-9.33
226.49%
2 Buy
1 Hold
0 Sell
Moderate Buy
TOT BIOPHARM International Co. Ltd.
HK$2.50
HK$3.76B
-16.66
181.29%
Jiangsu Recbio Technology Co., Ltd. Class H
HK$4.18
HK$2.35B
-3.21
-27.75%
SinoMab Bioscience Ltd.
HK$1.39
HK$2.24B
-14.44
46.02%
Immunotech Biopharm Ltd
HK$2.68
HK$2.16B
-6.43
-1.13%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
HK:6996
Antengene Corporation Limited
5.79
3.06
112.09%
HK:1672
Ascletis Pharma, Inc.
17.50
11.73
203.29%
HK:1875
TOT BIOPHARM International Co. Ltd.
4.81
3.18
195.09%
HK:2179
Jiangsu Recbio Technology Co., Ltd. Class H
5.00
-1.92
-27.75%
HK:3681
SinoMab Bioscience Ltd.
1.65
0.50
43.48%
HK:6978
Immunotech Biopharm Ltd
3.59
-0.15
-4.01%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts